158 related articles for article (PubMed ID: 33316896)
21. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
[TBL] [Abstract][Full Text] [Related]
22. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
Staal J; Driege Y; Van Gaever F; Steels J; Beyaert R
FEBS J; 2024 Mar; 291(6):1220-1245. PubMed ID: 38098267
[TBL] [Abstract][Full Text] [Related]
23. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN
J Invest Dermatol; 2015 Dec; 135(12):2964-2970. PubMed ID: 26203641
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action.
Shi HX; Liu X; Wang Q; Tang PP; Liu XY; Shan YF; Wang C
PLoS Pathog; 2011 May; 7(5):e1002057. PubMed ID: 21625535
[TBL] [Abstract][Full Text] [Related]
25. Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated.
Kanda N
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804147
[TBL] [Abstract][Full Text] [Related]
26. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
27. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.
Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH
J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989
[TBL] [Abstract][Full Text] [Related]
28. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
[TBL] [Abstract][Full Text] [Related]
29. STUB1 is essential for T-cell activation by ubiquitinating CARMA1.
Wang S; Li Y; Hu YH; Song R; Gao Y; Liu HY; Shu HB; Liu Y
Eur J Immunol; 2013 Apr; 43(4):1034-41. PubMed ID: 23322406
[TBL] [Abstract][Full Text] [Related]
30. Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.
Suleman S; Chhabra G; Raza R; Hamid A; Qureshi JA; Ahmad N
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012602
[TBL] [Abstract][Full Text] [Related]
31. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.
Jattani RP; Tritapoe JM; Pomerantz JL
J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334
[TBL] [Abstract][Full Text] [Related]
32. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
[TBL] [Abstract][Full Text] [Related]
33. MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.
Van Nuffel E; Staal J; Baudelet G; Haegman M; Driege Y; Hochepied T; Afonina IS; Beyaert R
EMBO Rep; 2020 Jul; 21(7):e49237. PubMed ID: 32343482
[TBL] [Abstract][Full Text] [Related]
34. CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
Ammar M; Jordan CT; Cao L; Lim E; Bouchlaka Souissi C; Jrad A; Omrane I; Kouidhi S; Zaraa I; Anbunathan H; Mokni M; Doss N; Guttman-Yassky E; El Gaaied AB; Menter A; Bowcock AM
Br J Dermatol; 2016 Feb; 174(2):330-7. PubMed ID: 26358359
[TBL] [Abstract][Full Text] [Related]
35. E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells.
Song X; Liu S; Wang W; Ma Z; Cao X; Jiang M
Cell Mol Immunol; 2020 Aug; 17(8):865-874. PubMed ID: 31076723
[TBL] [Abstract][Full Text] [Related]
36. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
[TBL] [Abstract][Full Text] [Related]
37. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B.
Wang L; Guo Y; Huang WJ; Ke X; Poyet JL; Manji GA; Merriam S; Glucksmann MA; DiStefano PS; Alnemri ES; Bertin J
J Biol Chem; 2001 Jun; 276(24):21405-9. PubMed ID: 11259443
[TBL] [Abstract][Full Text] [Related]
38. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.
Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S
J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426
[TBL] [Abstract][Full Text] [Related]
39. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
40. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
